HEPION PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
HEPION PHARMACEUTICALS, INC. (HEPA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 9.68 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-03-31
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 16.83M shares, a 370.79% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 9.03M shares, a 161.32% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 8.49M shares, a 887.93% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 4.35M shares, a 1637.40% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 9.68M shares, a 373.65% increase from fiscal 2019.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.04M shares, a 1011.19% increase from fiscal 2018.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 183.88K shares, a 98.10% decline from fiscal 2017.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 9.68M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 2 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 16.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 12.93M shares derived: average of 2 quarters · filed 2021-03-31 | 11.45M shares derived: average of 3 quarters · filed 2021-03-31 | 9.68M shares 10-K · filed 2021-03-31 | ||||
| 2020-09-30 | 9.03M shares 10-Q · filed 2020-11-16 | 8.76M shares derived: average of 2 quarters · filed 2020-11-16 | 7.29M shares 10-Q · filed 2020-11-16 | 6.36M shares derived: average of 4 quarters · filed 2021-03-31 | ||||
| 2020-06-30 | 8.49M shares 10-Q · filed 2020-08-12 | 6.42M shares 10-Q · filed 2020-08-12 | 5.47M shares derived: average of 3 quarters · filed 2021-03-31 | 4.97M shares derived: average of 4 quarters · filed 2021-03-31 | ||||
| 2020-03-31 | 4.35M shares 10-Q · filed 2020-06-29 | 3.96M shares derived: average of 2 quarters · filed 2021-03-31 | 3.79M shares derived: average of 3 quarters · filed 2021-03-31 | 3.06M shares derived: average of 4 quarters · filed 2021-03-31 | ||||
| 2019-12-31 | 3.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 3.51M shares derived: average of 2 quarters · filed 2021-03-31 | 2.63M shares derived: average of 3 quarters · filed 2021-03-31 | 2.04M shares 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | 3.45M shares 10-Q · filed 2020-11-16 | 2.16M shares derived: average of 2 quarters · filed 2020-11-16 | 1.53M shares 10-Q · filed 2020-11-16 | 1.20M shares derived: average of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | 859.83K shares 10-Q · filed 2020-08-12 | 556.66K shares 10-Q · filed 2020-08-12 | 448.47K shares derived: average of 3 quarters · filed 2020-08-12 | 386.96K shares derived: average of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | 250.13K shares 10-Q · filed 2020-06-29 | 17.51M shares 10-Q · filed 2019-05-15 | 242.79K shares derived: average of 2 quarters · filed 2020-06-29 | 229.34K shares derived: average of 3 quarters · filed 2020-06-29 | 210.09K shares derived: average of 4 quarters · filed 2020-06-29 | |||
| 2018-12-31 | 235.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | 218.95K shares derived: average of 2 quarters · filed 2020-05-14 | 196.75K shares derived: average of 3 quarters · filed 2020-05-14 | 183.88K shares 10-K · filed 2020-05-14 | ||||
| 2018-09-30 | 202.45K shares 10-Q · filed 2019-11-14 | 14.17M shares 10-Q · filed 2018-11-14 | 177.40K shares derived: average of 2 quarters · filed 2019-11-14 | 166.69K shares 10-Q · filed 2019-11-14 | 11.67M shares 10-Q · filed 2018-11-14 | 7.71M shares derived: average of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | 152.34K shares 10-Q · filed 2019-08-14 | 10.66M shares 10-Q · filed 2018-08-14 | 148.51K shares 10-Q · filed 2019-08-14 | 10.40M shares 10-Q · filed 2018-08-14 | 10.21M shares derived: average of 3 quarters · filed 2019-08-14 | 9.53M shares derived: average of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | 10.12M shares 10-Q · filed 2019-05-15 | 80.99M shares 10-Q · filed 2018-05-15 | 15.23M shares derived: average of 2 quarters · filed 2019-05-15 | 12.66M shares derived: average of 3 quarters · filed 2019-05-15 | 11.37M shares derived: average of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | 20.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 13.93M shares derived: average of 2 quarters · filed 2019-03-14 | 11.79M shares derived: average of 3 quarters · filed 2019-03-14 | 9.68M shares 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | 7.51M shares 10-Q · filed 2018-11-14 | 76.58M shares 10-Q · filed 2017-11-14 | 7.51M shares derived: average of 2 quarters · filed 2018-11-14 | 6.12M shares 10-Q · filed 2018-11-14 | 34.59M shares derived: average of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | 7.51M shares 10-Q · filed 2018-08-14 | 6.12M shares 10-Q · filed 2018-08-14 | 43.62M shares derived: average of 3 quarters · filed 2018-08-14 | 42.20M shares derived: average of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | 63.30M shares 10-Q · filed 2018-05-15 | 61.68M shares derived: average of 2 quarters · filed 2018-05-15 | 53.69M shares 10-Q · filed 2017-04-12 | 48.33M shares derived: average of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | 60.05M shares 10-Q · filed 2017-02-14 | 48.99M shares 10-Q · filed 2017-02-14 | 43.34M shares derived: average of 3 quarters · filed 2017-11-14 | 39.33M shares derived: average of 4 quarters · filed 2017-11-14 | ||||
| 2016-09-30 | 37.92M shares 10-Q · filed 2017-11-14 | 34.98M shares derived: average of 2 quarters · filed 2017-11-14 | 32.42M shares derived: average of 3 quarters · filed 2017-11-14 | 30.97M shares derived: average of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | 32.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | 29.66M shares derived: average of 2 quarters · filed 2017-04-12 | 28.66M shares derived: average of 3 quarters · filed 2017-04-12 | 27.06M shares 10-K · filed 2016-09-28 | ||||
| 2016-03-31 | 27.30M shares 10-Q · filed 2017-04-12 | 26.97M shares derived: average of 2 quarters · filed 2017-04-12 | 25.40M shares 10-Q · filed 2017-04-12 | 25.56M shares derived: average of 4 quarters · filed 2017-04-12 | ||||
| 2015-12-31 | 26.64M shares 10-Q · filed 2017-02-14 | 24.47M shares 10-Q · filed 2017-02-14 | 24.98M shares derived: average of 3 quarters · filed 2017-02-14 | 24.31M shares derived: average of 4 quarters · filed 2017-02-14 | ||||
| 2015-09-30 | 22.29M shares 10-Q · filed 2016-11-14 | 24.15M shares derived: average of 2 quarters · filed 2016-11-14 | 23.53M shares derived: average of 3 quarters · filed 2016-11-14 | 23.21M shares derived: average of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | 26.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | 24.14M shares derived: average of 2 quarters · filed 2016-09-28 | 23.52M shares derived: average of 3 quarters · filed 2016-09-28 | 21.75M shares 10-K · filed 2016-09-28 | ||||
| 2015-03-31 | 22.27M shares 10-Q · filed 2016-05-13 | 22.27M shares derived: average of 2 quarters · filed 2016-05-13 | 20.33M shares 10-Q · filed 2016-05-13 | 20.83M shares derived: average of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | 22.27M shares 10-Q · filed 2016-02-12 | 21.24M shares 10-Q · filed 2016-02-12 | 20.35M shares derived: average of 3 quarters · filed 2016-02-12 | 18.94M shares derived: average of 4 quarters · filed 2016-02-12 | ||||
| 2014-09-30 | 20.21M shares 10-Q · filed 2015-11-12 | 19.38M shares derived: average of 2 quarters · filed 2015-11-12 | 17.83M shares derived: average of 3 quarters · filed 2015-11-12 | 15.63M shares derived: average of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | 18.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | 16.65M shares derived: average of 2 quarters · filed 2015-09-25 | 14.10M shares derived: average of 3 quarters · filed 2015-09-25 | 12.82M shares 10-K · filed 2015-09-25 | ||||
| 2014-03-31 | 14.74M shares 10-Q · filed 2015-05-14 | 11.87M shares derived: average of 2 quarters · filed 2015-05-14 | 10.90M shares 10-Q · filed 2015-05-14 | |||||
| 2013-12-31 | 9.00M shares 10-Q · filed 2015-02-12 | 9.00M shares 10-Q · filed 2015-02-12 | ||||||
| 2013-09-30 | 9.00M shares 10-Q · filed 2014-11-13 | |||||||
| 2013-06-30 | 9.00M shares 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |